Page last updated: 2024-09-03

parecoxib and Cardiovascular Stroke

parecoxib has been researched along with Cardiovascular Stroke in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbate, A; Hoke, NN; Houser, JE; Ownby, ED; Salloum, FN; Seropian, IM; Van Tassell, BW; Varma, A	1
Aldington, S; Beasley, R; Shirtcliffe, P; Weatherall, M	1
Abbate, A; Baldi, A; Biasucci, LM; Biondi-Zoccai, GG; Capogrossi, MC; Crea, F; Das, A; Kukreja, RC; Mellone, P; Ockaili, RA; Piro, M; Qureshi, IZ; Salloum, FN; Severino, A; Straino, S; Vetrovec, GW	1

Reviews

1 review(s) available for parecoxib and Cardiovascular Stroke

Article	Year
Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. The New Zealand medical journal, 2005, Nov-25, Volume: 118, Issue:1226 Topics: Cardiac Surgical Procedures; Cardiovascular Diseases; Cerebrovascular Disorders; Cyclooxygenase Inhibitors; Humans; Isoxazoles; Myocardial Infarction; Odds Ratio; Outcome and Process Assessment, Health Care; Pain, Postoperative; Risk Factors; Sulfonamides; Survival Analysis	2005

Article

Year

Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis.

The New Zealand medical journal, 2005, Nov-25, Volume: 118, Issue:1226

Topics: Cardiac Surgical Procedures; Cardiovascular Diseases; Cerebrovascular Disorders; Cyclooxygenase Inhibitors; Humans; Isoxazoles; Myocardial Infarction; Odds Ratio; Outcome and Process Assessment, Health Care; Pain, Postoperative; Risk Factors; Sulfonamides; Survival Analysis

2005

Other Studies

2 other study(ies) available for parecoxib and Cardiovascular Stroke

Article	Year
Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion. Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:6 Topics: Acute Disease; Animals; Apoptosis; Coronary Stenosis; Coronary Vessels; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Injections, Intraperitoneal; Isoxazoles; Ligation; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Ventricular Remodeling	2009
Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat. Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:5 Topics: Animals; Apoptosis; Arterioles; Cyclooxygenase 2 Inhibitors; Cytokines; Echocardiography; Heart; Isoxazoles; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Survival Analysis; Ventricular Remodeling	2007

Article

Year

Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion.

Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:6

Topics: Acute Disease; Animals; Apoptosis; Coronary Stenosis; Coronary Vessels; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Injections, Intraperitoneal; Isoxazoles; Ligation; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Ventricular Remodeling

2009

Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.

Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:5

Topics: Animals; Apoptosis; Arterioles; Cyclooxygenase 2 Inhibitors; Cytokines; Echocardiography; Heart; Isoxazoles; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Survival Analysis; Ventricular Remodeling

2007